THC
17.3–19.8%
CBD
0.1%
Lemon Cherry Pave is a Compound Genetics hybrid testing 17.3-19.8% THC, with flavor detail still unconfirmed publicly.
No effect, terpene, flavor or medical-use data specific to Lemon Cherry Pavé has been published yet, so we don't guess. For what hybrid strains usually do, see the effects guide.
THC in this profile
19.8% THC
About Lemon Cherry Pavé
Compound Genetics has built a name around dessert-and-fruit hybrid crosses, and Lemon Cherry Pave continues that pattern in name if not yet in documented detail - THC on this one lands between 17.3% and 19.8%, a comfortable mid-to-upper range that avoids the extremes found elsewhere in this lineup. No flavor list, terpene profile, or effect data has been published for this specific cut, which means the citrus-and-cherry promise baked into the name hasn't been confirmed through lab testing or reported grower experience. Compound Genetics' broader catalog has a strong reputation among collectors who chase newer, harder-to-find crosses, and a name this specific and evocative fits that mold closely. For anyone building out a collection of trendier modern hybrids, Lemon Cherry Pave is worth tracking even before more public detail catches up to the name.
Where to Buy Seeds
We may earn a commission from purchases made through these links.
Frequently Asked Questions about Lemon Cherry Pavé
Is Lemon Cherry Pavé an Indica, Sativa, or Hybrid?
Lemon Cherry Pavé is classified as a hybrid cannabis strain.
What cannabinoid content is reported for Lemon Cherry Pavé?
Lemon Cherry Pavé: 19.8% THC and 0.1% CBD reported in our data. The THC figure, when present, is the upper end of the reported range, not a typical measured dose. Potency can vary across harvests, phenotypes, and growing conditions.